Steven Cohen’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
Other funds holding ARCT
Steven Cohen's ARCT Position: Q3 2026 in Review
Steven Cohen reduced its Arcturus Therapeutics (ARCT) stake by 89% in Q3 2026, selling an estimated $2.16M and leaving 24,555 shares worth $336K. The position accounts for ﹤0.01% of the portfolio, ranked #3290.
Steven Cohen first reported a position in ARCT in Q2 2020 and has held it in 17 quarters since. The position peaked at $14.4M in Q2 2022. 155 funds tracked by Wall St. Rank hold ARCT as of Q3 2026.
- Steven Cohen held 24,555 shares of Arcturus Therapeutics worth $336K as of Q3 2026.
- Steven Cohen sold 207,027 Arcturus Therapeutics shares in Q3 2026, an estimated $2.16M.
- Arcturus Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3290 holding.
- Steven Cohen first reported a position in Arcturus Therapeutics in Q2 2020 and has held it in 17 quarters since.
- Steven Cohen's Arcturus Therapeutics position peaked at $14.4M in Q2 2022.
- 155 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.